Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4849553 | 0.75 | TYR (0.42) | — | |
| SCHEMBL4847156 | 0.72 | — | — | |
| SCHEMBL6691869 | 0.70 | LMNA (0.36) | — | |
| SCHEMBL4856944 | 0.69 | L3MBTL1 (0.32) | L3MBTL1 | |
| SCHEMBL6692747 | 0.69 | ALPG (0.31) | — | |
| SCHEMBL6695378 | 0.68 | KMT2A (0.53) | ALDH1A1HPGDL3MBTL1 | |
| SCHEMBL6698458 | 0.67 | — | — | |
| SCHEMBL6696061 | 0.67 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL6694826 | 0.67 | CHRM2 (0.42) | ALDH1A1HPGDL3MBTL1 | |
| Hydrochloric Acid SCHEMBL8129113 | 0.67 | KMT2A (0.51) | ALDH1A1HPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063780-A1 | Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes | CHUGAI SEIYAKU KABUSHIKI KAISHA | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063780-A1 | Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes | SLC5A2, SLC5A1, IAPP | ALDH1A1 1406/4885HPGD 1488/4885L3MBTL1 4313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.